M Moroni, C Porta, M De Amici, S Quaglini, MA Cattabiani, C Buzio. Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients. Haematologica 2000;85(3):298-303; https://doi.org/10.3324/%x.